17-7676041-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 10P and 1B. BP4PM5_StrongPS3PM2
This summary comes from the ClinGen Evidence Repository: The NM_000546.6: c.328C>G variant in TP53 is a missense variant predicted to cause substitution of arginine by glycine at amino acid 110 (p.Arg110Gly). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). Although this variant has been observed in germline cases, to our knowledge, this variant has not been reported in individuals meeting classical LFS or Chompret criteria (PS4 not met; Internal lab contributors). In vitro assays performed in yeast and/or human cell lines showed non-functional transactivation and loss of growth suppression activity indicating that this variant impacts protein function (PS3; PMIDs: 12826609, 30224644, 29979965). 2 different missense variants (p.Arg110Leu, p.Arg110Pro) (ClinVar Variation IDs: 406597, 233627), in the same codon have been classified as pathogenic for Li-Fraumeni syndrome by the ClinGen TP53 VCEP’s specifications. (PM5_Strong). Computational predictor scores (BayesDel = 0.056; Align GVGD Class C15) are below the recommended thresholds (BayesDel < 0.16 and > -0.008 and an Align GVGD Class ≤ 55), evidence that does not predict a damaging effect on TP53 via protein change. SpliceAI predicts that the variant has no impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Likely Pathogenic for Li Fraumeni syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen TP53 VCEP: PM2_Supporting, PS3, PM5_Strong, BP4. (Bayesian Points: 8; VCEP specifications version 2.3) LINK:https://erepo.genome.network/evrepo/ui/classification/CA397844579/MONDO:0018875/009
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TP53 | MANE Select | c.328C>G | p.Arg110Gly | missense | Exon 4 of 11 | NP_000537.3 | |||
| TP53 | c.328C>G | p.Arg110Gly | missense | Exon 4 of 11 | NP_001119584.1 | K7PPA8 | |||
| TP53 | c.328C>G | p.Arg110Gly | missense | Exon 5 of 12 | NP_001394191.1 | K7PPA8 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TP53 | TSL:1 MANE Select | c.328C>G | p.Arg110Gly | missense | Exon 4 of 11 | ENSP00000269305.4 | P04637-1 | ||
| TP53 | TSL:1 | c.328C>G | p.Arg110Gly | missense | Exon 4 of 11 | ENSP00000391478.2 | P04637-1 | ||
| TP53 | TSL:1 | c.211C>G | p.Arg71Gly | missense | Exon 3 of 10 | ENSP00000478219.1 | P04637-4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at